Screen IBD patients for SpA

Gastroenterologists should screen for spondyloarthropathy (SpA) in all patients with inflammatory bowel disease and liaise with their rheumatology colleagues in developing the optimal treatment strategy, Canberra clinicians have claimed. Gastroenterologist Dr Kavitha Subramaniam, from Canberra Hospital, and colleagues found that 29% of 140 patients treated with TNF inhibitors for Crohn’s disease or ulcerative colitis had ...

Already a member?

Login to keep reading.

© 2021 the limbic